TANG CAPITAL MANAGEMENT LLC
Q2 2025 13F Holdings
- Locationsan diego, CA
- Num holdings
200
- Value ($000)
$1,978,391
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001232621
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
GLPG GALAPAGOS NV | SPON ADR | 36315X101 | $111.68M | 6 % | 3,990,111 | ||
TARS TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $99.44M | 5 % | 2,454,797 | ||
AUPH AURINIA PHARMACEUTICALS INC | COM | 05156V102 | $84.95M | 4 % | 10,029,500 | ||
IMCR IMMUNOCORE HLDGS PLC | ADS | 45258D105 | $66.07M | 3 % | 2,105,608 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | $64.43M | 3 % | 2,328,609 | ||
MIRM MIRUM PHARMACEUTICALS INC | COM | 604749101 | $62.90M | 3 % | 1,236,027 | ||
KALV KALVISTA PHARMACEUTICALS INC | COM | 483497103 | $55.87M | 3 % | 4,941,798 | ||
PTCT PTC THERAPEUTICS INC | COM | 69366J200 | $53.72M | 3 % | 1,100,000 | ||
SYRE SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | $47.90M | 2 % | 3,200,000 | ||
EOLS EVOLUS INC | COM | 30052C107 | $46.03M | 2 % | 4,997,399 |
Rows Per Page
10
- 10
- 50
- 100